2020 Annual Meeting | C232 - Autoimmune Neurology 1 Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes of the CNS and PNS

Date Thursday 04/30/20

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Stacey Clardy, MD, PhD, FAAN

Topic(s) Autoimmune Neurology

Learning Objectives Participants should be able to understand the autoantibody nomenclature; recognize autoimmune neurologic disorders; know the neurologic and cancer associations of the autoantibodies; know the pitfalls in antibody testing; know the appropriate oncological evaluations for paraneoplastic neurologic disorders; and know some frequently used treatment approaches for autoimmune neurologic disorders. They should be able to understand the importance of antigen location (synaptic/cell surface compared to intracellular antigen targets), and learn about the latest advances in autoimmune epilepsy.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Program Tracks Advanced Practice Provider, Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic, Audience Participation

Event Timeline
01:00 PM - 01:10 PM	Introduction	Introduction Stacey Clardy, MD, PhD, FAAN
01:10 PM - 01:40 PM	Speaker	An Introduction and Overview: Antibody-mediated CNS Disease Stacey Clardy, MD, PhD, FAAN
01:40 PM - 01:45 PM	Q&A	Questions and Answers
01:45 PM - 02:15 PM	Speaker	Synaptic Antibody-associated Neurologic Syndromes Marianna Spatola, MD, PhD
02:15 PM - 02:20 PM	Q&A	Questions and Answers
02:20 PM - 02:50 PM	Speaker	Autoimmune Epilepsy Sarosh R. Irani, MD, PhD, FRCP, FEAN
02:50 PM - 03:00 PM	Q&A	Questions and Answers

Faculty Disclosures
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Marianna Spatola, MD, PhD	The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation.
Sarosh R. Irani, MD, PhD, FRCP, FEAN	Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma.. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��

��ɫ��